Preliminary Clinical Study on the Use of Low-dosage Pituitrin in the Treatment of Refractory Shock

LUO Zhe,ZHU Duming,WU Zhaoguang
DOI: https://doi.org/10.3969/j.issn.1008-6358.2007.03.046
2007-01-01
Abstract:Objective:To study the effect of low-dosage pituitrin in clinical refractory shock.Methods:We retrospectively studied 17 ca- ses of refractory shock admitted to the surgical intensive care unit of Zhongshan hospital between March,2005 and January,2006.Pa- tients remained in shock despite volume resuscitation and administration of catecolamines were given low-dosage pituitrin(0.04 U/ min).When the mean arterial blood pressure was more than or equal to 65mmHg,the dosages of catecolamines were readjusted.Re- sults:The mean integrated dosages of catecolamines were 13.63±3.8 before administration of low-dosage pituitrin,and dropped to 3.01±0.648 hours after administration(P0.05).Mean urine output was 1.25±0.92ml·kg~(-1)h~(-1)before administration,and 2.02±1.15 ml·kg~(-1)h~(-1)8 hrs after administration(P0.05).Mean creatinine clearance ratio was 46.9±31.7ml·min~(-1)before adminis- tration,and 68.1±41.9ml·min~(-1)8 hrs after administration(P0.05).Conclusion:Low-dosage pituitrin could decrease the dosages of eatecolamines and improve renal function in patients with refractory shock.
What problem does this paper attempt to address?